Symptoms may include digestive issues, food sensitivities, skin conditions, frequent infections, and behavioral changes such as irritability or difficulty concentrating
While gastrointestinal AEs such as nausea and vomiting dominate safety reports 8 and recent pharmacovigilance studies highlight increasingly recognized risks including acute pancreatitis, nephritis, hypotension, and syncope 9,10,11 , emerging data suggest that GLP-1 RAs may be associated with neurological adverse events (NAEs) 12,13
[DOI] [PMC free article] [PubMed] [Google Scholar] 129.Cramer SL, Saha A, Liu J, Tadi S, Tiziani S, Yan W, Triplett K, Lamb C, Alters SE, Rowlinson S, et al
I try to impress this upon clinicians and people outside of the Lyme world, and I think that the COVID debacle has opened up their eyes to the fact that there are these pathogens, that the truth about their symptomology and their chronicity is not being disclosed to doctors, so they dont know what to do
This means that your healthcare provider must submit documentation to justify the medical necessity of the medication
Typical research applications include: Investigation of tissue regeneration pathways